Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Management of Glioblastoma, Present and Future.

Oberheim Bush NA, Hervey-Jumper SL, Berger MS.

World Neurosurg. 2019 Nov;131:328-338. doi: 10.1016/j.wneu.2019.07.044.

PMID:
31658576
2.

Current and future strategies for treatment of glioma.

Bush NA, Chang SM, Berger MS.

Neurosurg Rev. 2017 Jan;40(1):1-14. doi: 10.1007/s10143-016-0709-8. Epub 2016 Apr 16. Review.

PMID:
27085859
3.

Individualized targeted therapy for glioblastoma: fact or fiction?

Weller M, Stupp R, Hegi M, Wick W.

Cancer J. 2012 Jan-Feb;18(1):40-4. doi: 10.1097/PPO.0b013e318243f6c9. Review.

PMID:
22290256
4.

Recent advances and future of immunotherapy for glioblastoma.

Kamran N, Calinescu A, Candolfi M, Chandran M, Mineharu Y, Asad AS, Koschmann C, Nunez FJ, Lowenstein PR, Castro MG.

Expert Opin Biol Ther. 2016 Oct;16(10):1245-64. doi: 10.1080/14712598.2016.1212012. Epub 2016 Jul 27. Review.

5.

A Critical Overview of Targeted Therapies for Glioblastoma.

Jain KK.

Front Oncol. 2018 Oct 15;8:419. doi: 10.3389/fonc.2018.00419. eCollection 2018. Review.

6.

[Targeted therapy in glioblastoma: update and perspectives].

Idbaih A, Duran-Peña A, Alentorn A.

Bull Acad Natl Med. 2015 Nov;199(8-9):1323-1329. Review. French.

PMID:
29874421
7.

Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.

Polivka J Jr, Polivka J, Holubec L, Kubikova T, Priban V, Hes O, Pivovarcikova K, Treskova I.

Anticancer Res. 2017 Jan;37(1):21-33. Review.

PMID:
28011470
8.

Recent advances in targeted therapy for glioblastoma.

Mittal S, Pradhan S, Srivastava T.

Expert Rev Neurother. 2015;15(8):935-46. doi: 10.1586/14737175.2015.1061934. Epub 2015 Jun 28. Review.

PMID:
26118735
9.

Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.

Khansur E, Shah AH, Lacy K, Komotar RJ.

Cancer Invest. 2019;37(1):1-7. doi: 10.1080/07357907.2018.1479414. Epub 2019 Jan 11. Review.

PMID:
30632816
10.

Emerging therapies for glioblastoma.

Thomas AA, Brennan CW, DeAngelis LM, Omuro AM.

JAMA Neurol. 2014 Nov;71(11):1437-44. doi: 10.1001/jamaneurol.2014.1701. Review.

PMID:
25244650
11.

New therapeutic approaches for malignant glioma: in search of the Rosetta stone.

Auffinger B, Thaci B, Nigam P, Rincon E, Cheng Y, Lesniak MS.

F1000 Med Rep. 2012;4:18. Epub 2012 Sep 5.

12.

Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.

Malric L, Monferran S, Gilhodes J, Boyrie S, Dahan P, Skuli N, Sesen J, Filleron T, Kowalski-Chauvel A, Cohen-Jonathan Moyal E, Toulas C, Lemarié A.

Oncotarget. 2017 Aug 21;8(49):86947-86968. doi: 10.18632/oncotarget.20372. eCollection 2017 Oct 17. Review.

13.

Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts.

Franceschi E, Minichillo S, Brandes AA.

CNS Drugs. 2017 Aug;31(8):675-684. doi: 10.1007/s40263-017-0454-8. Review.

PMID:
28681349
14.

Combination therapy to checkmate Glioblastoma: clinical challenges and advances.

Ghosh D, Nandi S, Bhattacharjee S.

Clin Transl Med. 2018 Oct 16;7(1):33. doi: 10.1186/s40169-018-0211-8. Review.

15.

Biologic principles of immunotherapy for malignant gliomas.

Han SJ, Kaur G, Yang I, Lim M.

Neurosurg Clin N Am. 2010 Jan;21(1):1-16. doi: 10.1016/j.nec.2009.08.001. Review.

PMID:
19944962
16.

Molecular advances of brain tumors in radiation oncology.

Noda SE, El-Jawahri A, Patel D, Lautenschlaeger T, Siedow M, Chakravarti A.

Semin Radiat Oncol. 2009 Jul;19(3):171-8. doi: 10.1016/j.semradonc.2009.02.005. Review.

PMID:
19464632
17.

Advances in Immunotherapy for Glioblastoma Multiforme.

Huang B, Zhang H, Gu L, Ye B, Jian Z, Stary C, Xiong X.

J Immunol Res. 2017;2017:3597613. doi: 10.1155/2017/3597613. Epub 2017 Feb 19. Review.

18.

Glioblastoma and other malignant gliomas: a clinical review.

Omuro A, DeAngelis LM.

JAMA. 2013 Nov 6;310(17):1842-50. doi: 10.1001/jama.2013.280319. Review.

PMID:
24193082
19.

Glioblastoma targeted therapy: updated approaches from recent biological insights.

Touat M, Idbaih A, Sanson M, Ligon KL.

Ann Oncol. 2017 Jul 1;28(7):1457-1472. doi: 10.1093/annonc/mdx106. Review.

20.

Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials.

Lieberman F.

F1000Res. 2017 Oct 26;6:1892. doi: 10.12688/f1000research.11493.1. eCollection 2017. Review.

Supplemental Content

Support Center